Abstract
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: Patent Selections
Volume: 1 Issue: 1
Author(s): Bentham Science Publisher
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publisher , Patent Selections, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2007; 1 (1) . https://dx.doi.org/10.2174/187221407779814543
DOI https://dx.doi.org/10.2174/187221407779814543 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
11
Related Articles
-
Endocytosis, Intracellular Traffic and Fate of Cell Penetrating Peptide Based Conjugates and Nanoparticles
Current Pharmaceutical Design Organ Preference of Cancer Metastasis and Metastasis-Related Cell Adhesion Molecules Including Carbohydrates
Cardiovascular & Hematological Disorders-Drug Targets Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Use of Grape Polyphenols for Promoting Human Health: A Review of Patents
Recent Patents on Food, Nutrition & Agriculture Prospective Clinical Applications of CRF Peptide Antagonists
Current Molecular Pharmacology Meet the Editorial Board
Combinatorial Chemistry & High Throughput Screening Growth Responses Following a Single Intra-Muscular hGH Plasmid Administration Compared to Daily Injections of hGH in Dwarf Mice
Current Gene Therapy Amyloidosis and Auto-Inflammatory Syndromes
Current Drug Targets - Inflammation & Allergy CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Genetic Variation in SLCO2B1 is Associated with Serum Levels of Testosterone and its Metabolites Prior to and Two Days after Testosterone Administration
Current Pharmacogenomics and Personalized Medicine Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Current Cancer Drug Targets CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry Zebrafish As a Genetic Model in Pre-Clinical Drug Testing and Screening
Current Medicinal Chemistry Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
Current Neuropharmacology Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy
Current Drug Targets The Hypothalamic-Pituitary-Adrenal Axis: What can it Tell us About Stressors?
CNS & Neurological Disorders - Drug Targets Dysfunction of Mitochondrial ATP Production As a Target for Personalized Cancer Therapy
Current Pharmacogenomics and Personalized Medicine Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Current Pharmaceutical Design